SC 13G

Company

ROCKET PHARMACEUTICALS, INC.

Filed

August 3, 2015

Accession Number

0001410578-15-000378

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →